COURSERA INC (COUR) Fundamental Analysis & Valuation

NYSE:COUR • US22266M1045

Current stock price

6.2186 USD
+0.16 (+2.62%)
Last:

This COUR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. COUR Profitability Analysis

1.1 Basic Checks

  • COUR had positive earnings in the past year.
  • In the past year COUR had a positive cash flow from operations.
  • In the past 5 years COUR always reported negative net income.
  • COUR had a positive operating cash flow in 4 of the past 5 years.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -5.10%, COUR is doing worse than 63.01% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -8.02%, COUR is in line with its industry, outperforming 49.32% of the companies in the same industry.
Industry RankSector Rank
ROA -5.1%
ROE -8.02%
ROIC N/A
ROA(3y)-8.77%
ROA(5y)-11.99%
ROE(3y)-13.42%
ROE(5y)-17.02%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

1.3 Margins

  • Looking at the Gross Margin, with a value of 54.57%, COUR is in the better half of the industry, outperforming 67.12% of the companies in the same industry.
  • In the last couple of years the Gross Margin of COUR has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for COUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.82%
GM growth 5Y0.7%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

7

2. COUR Health Analysis

2.1 Basic Checks

  • COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • COUR has more shares outstanding than it did 1 year ago.
  • COUR has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • Based on the Altman-Z score of 1.55, we must say that COUR is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of COUR (1.55) is comparable to the rest of the industry.
  • COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.55
ROIC/WACCN/A
WACC8.92%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • COUR has a Current Ratio of 2.51. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
  • COUR has a Current ratio of 2.51. This is amongst the best in the industry. COUR outperforms 83.56% of its industry peers.
  • COUR has a Quick Ratio of 2.51. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
  • COUR has a better Quick ratio (2.51) than 84.93% of its industry peers.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 2.51
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

5

3. COUR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 17.65% over the past year.
  • Looking at the last year, COUR shows a quite strong growth in Revenue. The Revenue has grown by 9.04% in the last year.
  • The Revenue has been growing by 20.88% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)17.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)9.04%
Revenue growth 3Y13.09%
Revenue growth 5Y20.88%
Sales Q2Q%9.89%

3.2 Future

  • Based on estimates for the next years, COUR will show a very strong growth in Earnings Per Share. The EPS will grow by 20.72% on average per year.
  • Based on estimates for the next years, COUR will show a small growth in Revenue. The Revenue will grow by 6.72% on average per year.
EPS Next Y9.85%
EPS Next 2Y15.55%
EPS Next 3Y20.72%
EPS Next 5YN/A
Revenue Next Year7.93%
Revenue Next 2Y7.26%
Revenue Next 3Y6.72%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 0.6

5

4. COUR Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 15.55, the valuation of COUR can be described as correct.
  • Based on the Price/Earnings ratio, COUR is valued a bit cheaper than the industry average as 71.23% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 25.96, COUR is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 14.15, COUR is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of COUR indicates a somewhat cheap valuation: COUR is cheaper than 76.71% of the companies listed in the same industry.
  • COUR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.55
Fwd PE 14.15
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, COUR is valued a bit cheaper than the industry average as 78.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.32
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • COUR's earnings are expected to grow with 20.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.58
PEG (5Y)N/A
EPS Next 2Y15.55%
EPS Next 3Y20.72%

0

5. COUR Dividend Analysis

5.1 Amount

  • No dividends for COUR!.
Industry RankSector Rank
Dividend Yield 0%

COUR Fundamentals: All Metrics, Ratios and Statistics

COURSERA INC

NYSE:COUR (3/17/2026, 9:36:05 AM)

6.2186

+0.16 (+2.62%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)02-05
Earnings (Next)04-22
Inst Owners92.57%
Inst Owner Change11.89%
Ins Owners4.94%
Ins Owner Change-0.17%
Market Cap1.05B
Revenue(TTM)757.50M
Net Income(TTM)-51.00M
Analysts75.79
Price Target10.1 (62.42%)
Short Float %16.16%
Short Ratio5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.68%
Min EPS beat(2)-1.96%
Max EPS beat(2)17.31%
EPS beat(4)3
Avg EPS beat(4)25.3%
Min EPS beat(4)-1.96%
Max EPS beat(4)49.74%
EPS beat(8)7
Avg EPS beat(8)297.92%
EPS beat(12)11
Avg EPS beat(12)902.16%
EPS beat(16)14
Avg EPS beat(16)684.85%
Revenue beat(2)2
Avg Revenue beat(2)0.33%
Min Revenue beat(2)0.03%
Max Revenue beat(2)0.63%
Revenue beat(4)4
Avg Revenue beat(4)0.62%
Min Revenue beat(4)0.03%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.01%
Revenue beat(12)9
Avg Revenue beat(12)0.91%
Revenue beat(16)12
Avg Revenue beat(16)0.69%
PT rev (1m)-13.16%
PT rev (3m)-20.27%
EPS NQ rev (1m)-3.64%
EPS NQ rev (3m)-26.82%
EPS NY rev (1m)-5.25%
EPS NY rev (3m)-3.35%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)2.14%
Revenue NY rev (1m)1.67%
Revenue NY rev (3m)1.82%
Valuation
Industry RankSector Rank
PE 15.55
Fwd PE 14.15
P/S 1.38
P/FCF 13.32
P/OCF 9.62
P/B 1.65
P/tB 1.72
EV/EBITDA N/A
EPS(TTM)0.4
EY6.43%
EPS(NY)0.44
Fwd EY7.07%
FCF(TTM)0.47
FCFY7.51%
OCF(TTM)0.65
OCFY10.39%
SpS4.5
BVpS3.78
TBVpS3.62
PEG (NY)1.58
PEG (5Y)N/A
Graham Number5.83
Profitability
Industry RankSector Rank
ROA -5.1%
ROE -8.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.57%
FCFM 10.36%
ROA(3y)-8.77%
ROA(5y)-11.99%
ROE(3y)-13.42%
ROE(5y)-17.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.82%
GM growth 5Y0.7%
F-Score6
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 104.86%
Cap/Sales 3.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.51
Quick Ratio 2.51
Altman-Z 1.55
F-Score6
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)115.48%
Cap/Depr(5y)105.87%
Cap/Sales(3y)4.2%
Cap/Sales(5y)3.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
EPS Next Y9.85%
EPS Next 2Y15.55%
EPS Next 3Y20.72%
EPS Next 5YN/A
Revenue 1Y (TTM)9.04%
Revenue growth 3Y13.09%
Revenue growth 5Y20.88%
Sales Q2Q%9.89%
Revenue Next Year7.93%
Revenue Next 2Y7.26%
Revenue Next 3Y6.72%
Revenue Next 5YN/A
EBIT growth 1Y24.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year174.69%
EBIT Next 3Y69.52%
EBIT Next 5YN/A
FCF growth 1Y32.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.99%
OCF growth 3YN/A
OCF growth 5YN/A

COURSERA INC / COUR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COURSERA INC (COUR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to COUR.


What is the valuation status of COURSERA INC (COUR) stock?

ChartMill assigns a valuation rating of 5 / 10 to COURSERA INC (COUR). This can be considered as Fairly Valued.


How profitable is COURSERA INC (COUR) stock?

COURSERA INC (COUR) has a profitability rating of 2 / 10.


What is the earnings growth outlook for COURSERA INC?

The Earnings per Share (EPS) of COURSERA INC (COUR) is expected to grow by 9.85% in the next year.